249 related articles for article (PubMed ID: 33419247)
1. Biological Activity of c-Peptide in Microvascular Complications of Type 1 Diabetes-Time for Translational Studies or Back to the Basics?
Ryk A; Łosiewicz A; Michalak A; Fendler W
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33419247
[TBL] [Abstract][Full Text] [Related]
2. C-peptide as a therapeutic tool in diabetic nephropathy.
Hills CE; Brunskill NJ; Squires PE
Am J Nephrol; 2010; 31(5):389-97. PubMed ID: 20357430
[TBL] [Abstract][Full Text] [Related]
3. Protective effect of C-peptide on experimentally induced diabetic nephropathy and the possible link between C-peptide and nitric oxide.
Elbassuoni EA; Aziz NM; El-Tahawy NF
Appl Physiol Nutr Metab; 2018 Jun; 43(6):617-624. PubMed ID: 29351386
[TBL] [Abstract][Full Text] [Related]
4. Diabetic neuropathy in type 1 and type 2 diabetes and the effects of C-peptide.
Sima AA
J Neurol Sci; 2004 May; 220(1-2):133-6. PubMed ID: 15140622
[No Abstract] [Full Text] [Related]
5. Cellular and physiological effects of C-peptide.
Hills CE; Brunskill NJ
Clin Sci (Lond); 2009 Apr; 116(7):565-74. PubMed ID: 19243312
[TBL] [Abstract][Full Text] [Related]
6. C-peptide, Na+,K(+)-ATPase, and diabetes.
Vague P; Coste TC; Jannot MF; Raccah D; Tsimaratos M
Exp Diabesity Res; 2004; 5(1):37-50. PubMed ID: 15198370
[TBL] [Abstract][Full Text] [Related]
7. Can C-peptide mediated anti-inflammatory effects retard the development of microvascular complications of type 1 diabetes?
Luppi P; Kallas Å; Wahren J
Diabetes Metab Res Rev; 2013 Jul; 29(5):357-62. PubMed ID: 23463541
[TBL] [Abstract][Full Text] [Related]
8. Beneficial effects of C-peptide on incipient nephropathy and neuropathy in patients with Type 1 diabetes mellitus.
Johansson BL; Borg K; Fernqvist-Forbes E; Kernell A; Odergren T; Wahren J
Diabet Med; 2000 Mar; 17(3):181-9. PubMed ID: 10784221
[TBL] [Abstract][Full Text] [Related]
9. Effects of C-peptide on microvascular blood flow and blood hemorheology.
Forst T; Kunt T
Exp Diabesity Res; 2004; 5(1):51-64. PubMed ID: 15198371
[TBL] [Abstract][Full Text] [Related]
10. [Proinsulin C-peptide -- the bioactive peptide with a huge promise].
Walenciak Ł; Fendler W; Młynarski W
Pediatr Endocrinol Diabetes Metab; 2007; 13(2):95-8. PubMed ID: 17880815
[TBL] [Abstract][Full Text] [Related]
11. Dipeptidyl peptidase-4 inhibitor ameliorates early renal injury through its anti-inflammatory action in a rat model of type 1 diabetes.
Kodera R; Shikata K; Takatsuka T; Oda K; Miyamoto S; Kajitani N; Hirota D; Ono T; Usui HK; Makino H
Biochem Biophys Res Commun; 2014 Jan; 443(3):828-33. PubMed ID: 24342619
[TBL] [Abstract][Full Text] [Related]
12. Effect of C-peptide on diabetic neuropathy in patients with type 1 diabetes.
Ekberg K; Johansson BL
Exp Diabetes Res; 2008; 2008():457912. PubMed ID: 18350117
[TBL] [Abstract][Full Text] [Related]
13. C-peptide: a new potential in the treatment of diabetic nephropathy.
Wahren J; Ekberg K; Samnegård B; Johansson BL
Curr Diab Rep; 2001 Dec; 1(3):261-6. PubMed ID: 12643208
[TBL] [Abstract][Full Text] [Related]
14. C-peptide: new findings and therapeutic possibilities.
Wahren J; Larsson C
Diabetes Res Clin Pract; 2015 Mar; 107(3):309-19. PubMed ID: 25648391
[TBL] [Abstract][Full Text] [Related]
15. Effect of cilostazol in treating diabetes-associated microvascular complications.
Asal NJ; Wojciak KA
Endocrine; 2017 May; 56(2):240-244. PubMed ID: 28293857
[TBL] [Abstract][Full Text] [Related]
16. Effects of proinsulin C-peptide on nitric oxide, microvascular blood flow and erythrocyte Na+,K+-ATPase activity in diabetes mellitus type I.
Forst T; De La Tour DD; Kunt T; Pfützner A; Goitom K; Pohlmann T; Schneider S; Johansson BL; Wahren J; Löbig M; Engelbach M; Beyer J; Vague P
Clin Sci (Lond); 2000 Mar; 98(3):283-90. PubMed ID: 10677386
[TBL] [Abstract][Full Text] [Related]
17. [Physiological effects of C-peptide].
Tsimaratos M
Nephrologie; 2004; 25(5):155-61. PubMed ID: 15455788
[TBL] [Abstract][Full Text] [Related]
18. C-peptide replacement therapy as an emerging strategy for preventing diabetic vasculopathy.
Bhatt MP; Lim YC; Ha KS
Cardiovasc Res; 2014 Nov; 104(2):234-44. PubMed ID: 25239825
[TBL] [Abstract][Full Text] [Related]
19. The role of protein kinase C activation and the vascular complications of diabetes.
Das Evcimen N; King GL
Pharmacol Res; 2007 Jun; 55(6):498-510. PubMed ID: 17574431
[TBL] [Abstract][Full Text] [Related]
20. AMPK in microvascular complications of diabetes and the beneficial effects of AMPK activators from plants.
Shrikanth CB; Nandini CD
Phytomedicine; 2020 Jul; 73():152808. PubMed ID: 30935723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
